Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary evaluation of the safety, tolerability and feasibility regarding specific postoperative complications of an adjuvant treatment with catumaxomab administered after curative tumor resection subsequent to a neoadjuvant chemotherapy. Relevant efficacy parameters (e.g., DFS, OS) will be assessed during a post-treatment follow-up period of two years.
Critère d'inclusion
- Gastric Neoplasm malignant